Mar 14, 2025 / 12:00PM GMT
Operator
Good day, everyone, and welcome to today's Cellectis this full-year 2024 earnings conference call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-answer session. (Operator Instructions) Please note today's conference is being recorded. I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Arthur Stril. Please go ahead.
Arthur Stril - Cellectis SA - Chief Business Officer, Member of the Executive Committee
Good morning, and welcome everyone to Cellectis fourth quarter and full-year 2024 business update and financial results conference call. Joining me on the call today are Doctor Andre Choulika, our Chief Executive Officer; and Doctor Adrian Kilcoyne, our Chief Medical Officer.
Yesterday evening, Cellectis issued a [6K-M] press release reporting our financial statements for the 12-month period ended December 30 2024 and a business update. The reports and press release are available on our website at cellectis.com.
Q4 2024 Cellectis SA Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
